Sources | Names Used |
---|---|
CTRPv2 | selumetinib:UNC0638 (4:1 mol/mol) |
PharmacoGx | selumetinib:UNC0638 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SAP30 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-08 |
mRNA | WDCP | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-09 |
mRNA | SKA1 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-09 |
mRNA | POLA1 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-09 |
mRNA | SENP1 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
mRNA | RFC4 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-10 |
mRNA | SPECC1L | CTRPv2 | pan-cancer | AAC | -0.22 | 8e-10 |
mRNA | ITPRIPL1 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-07 |
mRNA | DCK | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-07 |
mRNA | C16orf87 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-09 |